Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

NCT02468375 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02468375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02468375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
December 31, 2017
Enrollment
434 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder